References
Zhang C, Yang R, Wang X, Tao Y, Tang S, Tian Z, Zhou Y. LI-RADS morphological type predicts prognosis of patients with hepatocellular carcinoma after radical resection. Ann Surg Oncol. 2023;30(8):4876–85. https://doi.org/10.1245/s10434-023-13494-4.
Nevola R, Ruocco R, Criscuolo L, Villani A, Alfano M, Beccia D, Imbriani S, Claar E, Cozzolino D, Sasso FC, Marrone A, Adinolfi LE, Rinaldi L. Predictors of early and late hepatocellular carcinoma recurrence. World J Gastroenterol. 2023;29(8):1243–60. https://doi.org/10.3748/wjg.v29.i8.1243.
Chan AWH, Zhong J, Berhane S, Toyoda H, Cucchetti A, Shi K, Tada T, Chong CCN, Xiang BD, Li LQ, Lai PBS, Mazzaferro V, Garcia-Finana M, Kudo M, Kumada T, Roayaie S, Johnson PJ. Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection. J Hepatol. 2018;69(6):1284–93. https://doi.org/10.1016/j.jhep.2018.08.027.
Zhang W, Zhang B, Chen XP. Adjuvant treatment strategy after curative resection for hepatocellular carcinoma. Front Med. 2021;15(2):155–69. https://doi.org/10.1007/s11684-021-0848-3.
Huang G, Li PP, Lau WY, Pan ZY, Zhao LH, Wang ZG, Wang MC, Zhou WP. Antiviral therapy reduces hepatocellular carcinoma recurrence in patients with low HBV-DNA Levels: a randomized controlled trial. Ann Surg. 2018;268(6):943–54. https://doi.org/10.1097/SLA.0000000000002727.
Wang Z, Ren Z, Chen Y, Hu J, Yang G, Yu L, Yang X, Huang A, Zhang X, Zhou S, Sun H, Wang Y, Ge N, Xu X, Tang Z, Lau W, Fan J, Wang J, Zhou J. Adjuvant transarterial chemoembolization for HBV-related hepatocellular carcinoma after resection: a randomized controlled study. Clin Cancer Res. 2018;24(9):2074–81. https://doi.org/10.1158/1078-0432.CCR-17-2899.
Funding
No funding.
Author information
Authors and Affiliations
Contributions
QR: conceptualization, original draft, project administration. YW: writing, review and editing.
Corresponding author
Ethics declarations
Disclosure
The authors disclose no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ren, Q., Wang, Y. Letter to the Editor: Comment on: “LI‑RADS Morphological Type Predicts Prognosis of Patients with Hepatocellular Carcinoma After Radical Resection”. Ann Surg Oncol 30, 8023–8024 (2023). https://doi.org/10.1245/s10434-023-14444-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-023-14444-w